Image credit: Brian Shamblen

Parallel, MedMen Dumped $1 Million Into Legalization In Florida Last Month

An industry-backed effort posted another strong month of fundraising, while a grassroots campaign continued to fall short. Both campaigns remain far from their signature goals.

Florida
CBD

In a First, a Cannabis-Derived Pharma Product Is Descheduled in the US

The DEA has taken Epidiolex, a CBD-based formula for rare forms of epilepsy, completely off its list of controlled substances. Why? The 2018 Farm Bill.

Lobbying

The Cannabis Industry Spent More On Lobbying Than Ever Before in 2019. What’s Next is Unclear.

Companies and organizations spent nearly $11 million on federal lobbying alone, vastly outpacing previous years. But given the coronavirus, 2020 is a mystery.

Newsletter

Canada: medical cannabis is essential • Canopy’s board transformation • Australia’s cannabis access review • & more…

An excerpt from recent editions of the Cannabis Wire Daily newsletter.